As part of an international clinical trial, Jacksonville-based Mayo Clinic in Florida has become the first U.S. site to target metastatic breast cancer with the radiopharmaceutical actinium-225. The ...

Mayo Clinic says the therapy uses an alpha-emitting radiopharmaceutical designed to target cancer cells precisely without ...

Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of ...